Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
Hammarsten J, Högstedt B. Hammarsten J, et al. Among authors: hogstedt b. Eur Urol. 2001 Feb;39(2):151-8. doi: 10.1159/000052430. Eur Urol. 2001. PMID: 11223674
Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J, Högstedt B. Hammarsten J, et al. Among authors: hogstedt b. Scand J Urol Nephrol. 2002;36(5):330-8. doi: 10.1080/003655902320783827. Scand J Urol Nephrol. 2002. PMID: 12487736
Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hammarsten J, Högstedt B. Hammarsten J, et al. Among authors: hogstedt b. Blood Press. 2004;13(1):47-55. doi: 10.1080/08037050310025735. Blood Press. 2004. PMID: 15083641
Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
Hammarsten J, Högstedt B. Hammarsten J, et al. Among authors: hogstedt b. Eur J Cancer. 2005 Dec;41(18):2887-95. doi: 10.1016/j.ejca.2005.09.003. Epub 2005 Oct 20. Eur J Cancer. 2005. PMID: 16243513
Does transurethral resection of a clinically benign prostate gland increase the risk of developing clinical prostate cancer? A 10-year follow-up study.
Hammarsten J, Andersson S, Holmén A, Högstedt B, Peeker R. Hammarsten J, et al. Among authors: hogstedt b. Cancer. 1994 Oct 15;74(8):2347-51. doi: 10.1002/1097-0142(19941015)74:8<2347::aid-cncr2820740820>3.0.co;2-6. Cancer. 1994. PMID: 7522950
A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer.
Hammarsten J, Damber JE, Peeker R, Mellström D, Högstedt B. Hammarsten J, et al. Among authors: hogstedt b. Cancer Epidemiol. 2010 Oct;34(5):574-9. doi: 10.1016/j.canep.2010.06.014. Epub 2010 Aug 10. Cancer Epidemiol. 2010. PMID: 20702155
Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.
Hammarsten J, Högstedt B, Holthuis N, Mellström D. Hammarsten J, et al. Among authors: hogstedt b. Prostate Cancer Prostatic Dis. 1998 Mar;1(3):157-162. doi: 10.1038/sj.pcan.4500221. Prostate Cancer Prostatic Dis. 1998. PMID: 12496910 Free article.
Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.
Hammarsten J, Högstedt B. Hammarsten J, et al. Among authors: hogstedt b. Blood Press. 1999;8(1):29-36. doi: 10.1080/080370599438365. Blood Press. 1999. PMID: 10412880
Birthplace and social characteristics as risk factors for acute myocardial infarction in the province of Halland, Sweden.
Baigi A, Holmén A, Högstedt B, Odén A, Herrström P. Baigi A, et al. Among authors: hogstedt b. Public Health. 2002 Sep;116(5):279-84. doi: 10.1038/sj.ph.1900873. Public Health. 2002. PMID: 12209403
Life expectancy in the province of Halland, Sweden, 1911-50: the progress of public health in a long-living population.
Baigi A, Högstedt B, Odén A, Isacsson SO, Herrström P. Baigi A, et al. Among authors: hogstedt b. Scand J Public Health. 2002;30(3):231-7. doi: 10.1080/14034940210133979. Scand J Public Health. 2002. PMID: 12227980
87 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback